U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444294) titled 'A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults' on Feb. 11.
Brief Summary: A phase 1 study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of SRK-439 in healthy adults
Study Start Date: Nov. 21, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Placebo
Matching placebo to SRK-439, subcutaneous administration
DRUG: SRK-439
Single ascending dose, subcutaneous administration
DRUG: SRK-439
Multiple ascending dose, subcutaneous administration
Recruitment Status: RECRUITING
Sponsor: Scholar Rock, Inc.
Disclaimer: Curated by HT Syndication....